Loading
Spectrum Pharmaceuticals Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 02 Dec 2022.
Spectrum Pharmaceuticals Inc: what insiders have been doing
Every trade that managers of Spectrum Pharmaceuticals Inc disclose to SEC (Form 4) is tracked on this page. The company sits in the Healthcare & Pharma sector and is based in Henderson, United States. Spectrum Pharmaceuticals Inc has had no insider filing for more than a year; the last one goes back to 1 August 2023.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
55
Thresholds
n/a
Buy Volume
€21,793
1 ops. · all time
Sell Volume
€297,303
34 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2022FY ended December 2022 · cache
Income statement
RevenueUS$8.7M
Net income-US$64.9M-745.5% margin
Last declaration on 1 August 2023
Declarations55 total
27,380 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017680:0
54,066 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017672:0
295,244 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017668:0
317,474 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017669:0
29,759 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017677:0
104,823 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017673:0
67,660 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017675:0
195,485 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017679:0
463,005 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017673:1
32,387 shares@ US$1.096100.0% of flowCommon Stock, $0.001 par valueSEC:0000950170-23-025014:0
15,733 shares@ US$0.81917.9% of flowCommon Stock, $0.001 par valueSEC:0000950170-23-008619:0
18,153 shares@ US$0.81912.5% of flowCommon Stock, $0.001 par valueSEC:0000950170-23-008618:0
11,990 shares@ US$0.76112.8% of flowCommon Stock, $0.001 par valueSEC:0000899243-23-006112:0
14,607 shares@ US$0.7619.4% of flowCommon Stock, $0.001 par valueSEC:0000899243-23-006110:0
26,138 shares@ US$0.54419.5% of flowCommon Stock, $0.001 par valueSEC:0000899243-23-003145:0
69,389 shares@ US$0.54431.4% of flowCommon Stock, $0.001 par valueSEC:0000899243-23-003144:0
23,929 shares@ US$0.3827.7% of flowCommon Stock, $0.001 par valueSEC:0000899243-23-001066:0
222,000 shares0Common Stock, $0.001 par valueSEC:0000899243-23-001065:0
240,000 shares0Common Stock, $0.001 par valueSEC:0000899243-23-001064:0
50,000 shares@ US$0.4544.1% of flowCommon Stock, $0.001 par valueSEC:0000899243-22-037526:0
Canonical exit: 28 Feb 2023 (T+90)
50,000 shares@ US$0.4343.7% of flowCommon Stock, $0.001 par valueSEC:0001209191-22-054744:0
25,000 shares0Common Stock, $0.001 par valueSEC:0001209191-22-048515:0
25,000 shares0Common Stock, $0.001 par valueSEC:0001209191-22-048520:0
27,380 shares0Common Stock, $0.001 par valueSEC:0001209191-22-048497:0
25,000 shares0Common Stock, $0.001 par valueSEC:0001209191-22-048461:0
25 of 55 declarations
About Spectrum Pharmaceuticals Inc
Geographically, Spectrum has operated primarily from the United States and serves the U.S. market, with exposure to the country’s healthcare system, payers, and hospital distribution channels. SEC filings also show reliance on third-party manufacturers for certain inputs, active pharmaceutical ingredients, and logistics services, which is important when assessing operational resilience. In short, Spectrum Pharmaceuticals Inc. remains a U.S. biopharmaceutical stock listed on the NASDAQ, with a specialized and higher-risk profile, whose recent history has been defined by portfolio contraction, strategic refocusing, and greater dependence on a limited set of clinical and commercial catalysts.
